Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra M Poos

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
BMC Bioinformatics|January 1, 2020
Modelling TERT regulation across 19 different cancer types based on the MIPRIP 2.0 gene regulatory network approachAlexandra M Poos, Theresa Kordaß, Amol Kolte, et al.
Nucleic Acids Research|February 25, 2016
Mixed Integer Linear Programming based machine learning approach identifies regulators of telomerase in yeastAlexandra M Poos, André Maicher, Anna K Dieckmann, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|January 11, 2024
Sequence diversity of kappa light chains from patients with AL amyloidosis and multiple myelomaSarah Schreiner, Natalie Berghaus, Alexandra M Poos, et al.
Frontiers in Oncology|July 7, 2022
Inhibiting PI3K-AKT-mTOR Signaling in Multiple Myeloma-Associated Mesenchymal Stem Cells Impedes the Proliferation of Multiple Myeloma CellsLuca Heinemann, Klara Maria Möllers, Helal Mohammed Mohammed Ahmed, et al.
Leukemia|October 16, 2023
The landscape of small nucleolar RNA expression in multiple myeloma is determined by cytogenetic alterationsDuoduo Zhao, Christian Rohde, Stefanie Göllner, et al.
The FEBS Journal|April 25, 2023
Comparison of IGLV2-14 light chain sequences of patients with AL amyloidosis or multiple myelomaNatalie Berghaus, Sarah Schreiner, Alexandra M Poos, et al.
Blood Advances|August 17, 2022
Characterizing the role of the immune microenvironment in multiple myeloma progression at a single-cell levelCarolina Schinke, Alexandra M Poos, Michael Bauer, et al.
Nature Communications|August 3, 2022
The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory statesLeo Rasche, Carolina Schinke, Francesco Maura, et al.
Blood Cancer Journal|January 4, 2023
Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myelomaElias K Mai, Stefanie Huhn, Kaya Miah, et al.
Cell Death & Disease|November 18, 2022
An mTORC1 to HRI signaling axis promotes cytotoxicity of proteasome inhibitors in multiple myelomaOdai Darawshi, Barbara Muz, Shiri Gershon Naamat, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
BMC Bioinformatics|January 1, 2020
Modelling TERT regulation across 19 different cancer types based on the MIPRIP 2.0 gene regulatory network approachAlexandra M Poos, Theresa Kordaß, Amol Kolte, et al.
Nucleic Acids Research|February 25, 2016
Mixed Integer Linear Programming based machine learning approach identifies regulators of telomerase in yeastAlexandra M Poos, André Maicher, Anna K Dieckmann, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|January 11, 2024
Sequence diversity of kappa light chains from patients with AL amyloidosis and multiple myelomaSarah Schreiner, Natalie Berghaus, Alexandra M Poos, et al.
Frontiers in Oncology|July 7, 2022
Inhibiting PI3K-AKT-mTOR Signaling in Multiple Myeloma-Associated Mesenchymal Stem Cells Impedes the Proliferation of Multiple Myeloma CellsLuca Heinemann, Klara Maria Möllers, Helal Mohammed Mohammed Ahmed, et al.
Leukemia|October 16, 2023
The landscape of small nucleolar RNA expression in multiple myeloma is determined by cytogenetic alterationsDuoduo Zhao, Christian Rohde, Stefanie Göllner, et al.
The FEBS Journal|April 25, 2023
Comparison of IGLV2-14 light chain sequences of patients with AL amyloidosis or multiple myelomaNatalie Berghaus, Sarah Schreiner, Alexandra M Poos, et al.
Blood Advances|August 17, 2022
Characterizing the role of the immune microenvironment in multiple myeloma progression at a single-cell levelCarolina Schinke, Alexandra M Poos, Michael Bauer, et al.
Nature Communications|August 3, 2022
The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory statesLeo Rasche, Carolina Schinke, Francesco Maura, et al.
Blood Cancer Journal|January 4, 2023
Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myelomaElias K Mai, Stefanie Huhn, Kaya Miah, et al.
Cell Death & Disease|November 18, 2022
An mTORC1 to HRI signaling axis promotes cytotoxicity of proteasome inhibitors in multiple myelomaOdai Darawshi, Barbara Muz, Shiri Gershon Naamat, et al.
Pageof 3